Holding(s) in Company

Huveaux PLC 09 February 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii): Huveaux PLC 2. Reason for the notification (please place an X inside the appropriate bracket /s): An acquisition or disposal of voting rights: ( X ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): AXA S.A, 25 Avenue Matignon, 75008 Paris and its group of companies. 4. Full name of shareholder(s) (if different from 3.) (iv): ................. 5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v): 07/02/2007 6. Date on which issuer notified: 08/02/2007 7. Threshold(s) that is/are crossed or reached: 15% 8. Notified details: ................. A: Voting rights attached to shares Class/type of shares if Situation previous to the Triggering transaction (vi) possible using the ISIN CODE Number of shares Number of voting Rights (viii) Ord 3112957 31,667,790 31,667,790 Resulting situation after the triggering transaction (vii) Class/type of shares Number of Number of voting rights % of voting if possible using shares (ix) rights the ISIN CODE Direct Direct (x) Indirect (xi) Direct Indirect Ord 3112957 8,913,045 8,913,045 22,954,745 5.86% 15.10% B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Exercise/ Number of voting rights that may % of financial Date Conversion be acquired if the instrument is voting instrument (xiii) Period/ Date exercised/ converted. rights (xiv) Total (A+B) Number of voting rights % of voting rights 31,867,790 20.96% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): AXA Framlington 1,247,964 0.82% (Non - Beneficial) (Xerox Final Salary Pension Scheme) AXA Framlington 756,000 0.50% (Non - Beneficial) (Islington Group Pension Scheme) AXA Framlington 1,650,000 1.09% (Non - Beneficial) (SEI UK Equity) AXA Framlington 1,750,000 1.15% (Non - Beneficial) (Skandia UK global Best Ideas - GL) AXA Framlington 10,686,740 7.03% (Non - Beneficial) (Monthly Income) AXA Framlington 4,800,000 3.16% (Non - Beneficial) (UK Smaller Companies) AXA Framlington 1,085,479 0.71% (Non - Beneficial) (BAE Systems Pensions Fund CIF Trustees) AXA Framlington 475,647 0.31% (Non - Beneficial) (BAE Systems 2000 Pensions Fund) Framlington onshore private clients 502,915 0.33% (Non - Beneficial) Please note that this notification includes a disclosure on behalf of the following Investment Trust Companies which has/have a notifiable interest. The interest of each Trust is listed below - AXA Framlington Throgmorton Trust 6,500,000 4.28 % (Beneficial) Framlington Innovation Growth 2,413,045 1.59 % (Beneficial) Proxy Voting: 10. Name of the proxy holder: ................. 11. Number of voting rights proxy holder will cease to hold: ................. 12. Date on which proxy holder will cease to hold voting rights: ................. 13. Additional information: ................. 14. Contact name: Terry Marsh 15. Contact telephone number: 020 7003 2637 This information is provided by RNS The company news service from the London Stock Exchange

Companies

Merit Group (MRIT)
UK 100

Latest directors dealings